RGCB gets Rs 7 crore MAHA MedTech grant for cervical cancer blood test device
The Thiruvananthapuram institute is developing a nanopore-based device to detect cervical cancer biomarkers in blood. Its director said 33 proposals were picked from more than 1,000, The Indian Practitioner reports.
